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Abstract
We conducted a prospective multinational study of muscle pathology using magnetic resonance imaging (MRI) in patients
with limb-girdle muscular dystrophy 2I (LGMD2I). Thirty eight adult ambulant LGMD2I patients (19 male; 19 female) with
genetically identical mutations (c.826C.A) in the fukutin-related protein (FKRP) gene were recruited. In each patient, T1-
weighted (T1w) imaging was assessed by qualitative grading for 15 individual lower limb muscles and quantitative Dixon
imaging was analysed on 14 individual lower limb muscles by region of interest analysis. We described the pattern and
appearance of muscle pathology and gender differences, not previously reported for LGMD2I. Diffuse fat infiltration of the
gastrocnemii muscles was demonstrated in females, whereas in males fat infiltration was more prominent in the medial
than the lateral gastrocnemius (p = 0.05). In the anterior thigh of males, in contrast to females, median fat infiltration in the
vastus medialis muscle (45.7%) exceeded that in the vastus lateralis muscle (11.2%) (p,0.005). MRI is non-invasive, objective
and does not rely on patient effort compared to clinical and physical measures that are currently employed. We
demonstrated (i) that the quantitative Dixon technique is an objective quantitative marker of disease and (ii) new
observations of gender specific patterns of muscle involvement in LGMD2I.
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Introduction
Limb-girdle muscular dystrophy 2I (LGMD2I) is an autosomal
recessive disease caused most frequently by a homozygous founder
mutation (c.826C.A) in the fukutin-related protein gene (FKRP)
[1,2]. This condition is clinically heterogeneous with varying
presentations, including age of onset, rate of progression and
degree of severity. At the mild end of the spectrum, patients can
present with isolated asymptomatic hyperCKaemia in adulthood
and at the severe end of the spectrum, with a more progressive
disease resembling Duchenne muscular dystrophy with an early
onset in childhood. Respiratory and cardiac involvement is
frequently seen in LGMD2I patients and can occur independently
of the general muscle weakness [3–6].
While magnetic resonance imaging (MRI) can have a role in the
diagnostic workup of patients with inherited muscle diseases [7–
10], with MRI changes sometimes predating clinical/functional
changes [11], this is less important than genetic profiling in the
diagnosis of LGMD2I. However, quantitative fat imaging by
Dixon MRI can provide information about the state of fat
replacement in individual muscle groups as a measure of muscle
pathology. This information will be useful for clinical trials, since
for this purpose we must not study muscles that are too severely
affected at baseline and unlikely to respond to treatment, nor those
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which are not involved at all and unlikely to deteriorate in the
absence of treatment. To date, most MRI studies have used T1-
weighted (T1w) imaging in small numbers of patients, grading the
fat replacement on a 6-point visual scale. This is however,
subjective and does not permit discrimination of small changes in
muscle pathology.
In this study we have employed both qualitative T1w imaging
and quantitative fat imaging using the Dixon technique, to directly
compare these methods and describe the muscle involvement of
the cohort. The quantitative Dixon technique separates the fat and
the water components of the MR signal allowing the calculation of
tissue fat fraction, which is observer independent [12]. In addition,
it corrects for the inhomogeneity in magnetic and radiofrequency
fields, which makes signal intensity on T1w images difficult to
quantify (see Figures S1 and S2 in File S1 for illustration). In this
work, we have described in detail both the patterns of affected
muscles and their individual appearance on T1w images in
patients with LGMD2I. We have presented quantitative analysis
using the quantitative Dixon technique and have compared these
figures with the T1w qualitative scores. This objective quantitative
approach is vital for accurately defining the natural history of
skeletal muscle involvement in LGMD2I.
Materials and Methods
Setting and study population
This study complied with the Declaration of Helsinki, and
ethical approval for the Newcastle upon Tyne and London centers
was provided by the Newcastle and North Tyneside Research
Ethics Committee 2 (reference 09/H0907/29); the Regional
Committee on Biomedical Ethics of Copenhagen (reference H-
B-2009-061) provided approval for the Copenhagen centre; and
the Local Ethics Committee CPP-Ile-de-France VI (reference
2009-A00808-49) approved the Paris center. Written consent was
obtained from all participants. Thirty eight ambulant adults with a
genetically confirmed diagnosis of LGMD2I (19M:19F age 18–64
years, mean ages of 41.7 years and 39.5 years, respectively, and
disease duration 0–49 years) were recruited prospectively. We also
recruited 8 healthy adult controls (5M: 3F age range 23–61 years,
mean 40 years). Inclusion criteria were: identical genetic diagnosis
with homozygous c.826C.A FKRP mutations, ambulant for more
than 50 metres, no ventilator requirements and able to lie flat with
no contraindications for MRI scanning. Data were acquired
locally at the participating centres, using pre-agreed standardised
MRI protocols and clinical and functional assessments scores with
a standardised reporting method. Quality assurance was per-
formed for all centres prior to the study.
MRI techniques
The study consisted of (i) standard T1w imaging, allowing for
whole muscle qualitative evaluation and (ii) quantitative fat
imaging optimised for localised analysis of fat fraction. These
protocols were defined for use on 3.0 T scanners (Philips Intera
Achieva, Siemens TIM Trio) with surface-coil arrays for signal
detection.
i. T1w imaging. T1w imaging was performed with a turbo
spin echo sequence with the following parameters: Repetition
Time/Echo Time (TR/TE) = 671/10 ms (Newcastle/Paris) or
16 ms (London) or 12 ms (Copenhagen), number of averages 2,
acceleration factor 3, slice thickness 5 mm, interslice gap 10 mm,
2566192 matrix interpolated to 5126384. The field of view
(FOV) was 410 mm using multiple stacks to cover both legs from
the ankle to the pelvic crest. By specifying the sequence and
repetition time, equivalent fat/water contrast in the image was
achieved across the centres and this was verified in an acquisition
from a healthy volunteer before the patient data collection began.
ii. Quantitative Dixon imaging. Spoiled gradient echo
sequences were used. Protocol details varied slightly between sites.
Newcastle/London: 3-point Dixon images acquired in 2D with
TR/TE=100/3.45,4.6,5.75 ms, flip angle = 10 degrees, 10 slices
of 10 mm slice thickness, 5 mm gap; Paris: 3D, 64 slices of 5 mm
slice thickness with TR/TE=10/2.75,3.95,5.15 ms, flip angle = 3
degrees; Copenhagen: as per Paris, but with 36 slices per 3D
acquisition, 2-point Dixon with correction for B0 inhomogeneity
[13]. Optimal echo times were determined locally due to variation
in precise Bo magnitude between scanners. Images were collected
at mid-lower leg and mid-thigh. The central plane of acquisition
was defined with respect to bone landmarks as follows: legs were
positioned with the patella anterior; the lower leg images were
centred by finding the broadest part of the lower leg muscle, and
recording the distance from lower border of patella. Thigh images
were centred by locating superior border of patella, and the
anterior superior iliac spine, with centering 1/3 distance superior
to the patella; the distance was recorded for follow-up scans. Each
leg was imaged individually using 1606160 matrix interpolated to
2566256, FOV 2006200 mm. In Paris, it was possible to scan
both legs together at the same resolution using FOV
4486244 mm. The data was analysed to produce separate fat
and water images [13,14], see Figure S2 in File S1. Quantitative
fat fraction maps were produced by expressing the fat signal as a
percentage of the total signal per voxel.
Due to the need to use different scanners for implementation of
the Dixon method across the centres, two variations in the Dixon
method were used [13,14]. We ensured that the implementations
did not give different quantitative results by (i) agreeing equivalent
proton-density weighted protocols of a defined resolution, (ii)
running quantitative acquisitions on phantoms of known water-fat
composition with each implementation (by taking progressive
slices through a water-fat boundary) for comparison and (iii)
scanning control test subjects to ensure that equivalent regions of
interest could be marked on the images across the four centres.
iii. Interpretation. The images were analysed by one
consultant neurologist (TW). The T1w images were assessed on
an individual muscle basis and graded according to the scale
published by Mercuri et al. [15,16]. The quantitative fat images
were analysed by defining regions of interest (ROIs) in individual
muscles on the separated water image at the midpoint of both the
lower leg and thigh. The muscle groups analysed were, in the
upper leg, the biceps femoris long head and short head,
semitendinosus, semimembranosus, sartorius, gracilis, rectus
femoris, vastus lateralis and vastus medialis muscles; in the lower
leg, muscle groups analysed were the tibialis anterior, soleus,
peroneus longus, and lateral and medial gastrocnemius muscles.
To assess the objectivity of the measurements made, independent
grading of T1w images and ROI assessment of quantitative Dixon
images in all muscle groups in a randomly-selected subset of 8
patients (2 from each centre) was performed by KGH, an MR
physicist with 6 years’ experience of muscle imaging. Bland-
Altman analysis was performed on the quantitative Dixon imaging
results from the 14 muscle groups on each of the subjects to assess
bias and reproducability [17], while the intraclass correlation
coefficient was calculated for the gradings. The intrinsic repeat-
ability of the technique and positioning was assessed on 6 control
subjects by acquiring quantitative fat images twice in close
succession, removing the subjects from the scanner and reposi-
tioning them. The same ROIs analysed in the patients were
analyzed by the same observer (KGH).
Quantitative MRI in LGMD2I
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Table 1. Summary table of the clinical characteristics of the LGMD2I cohort (n = 38).
Patient Sex Age (years) First symptom
Age First
Symptom Serum CK Cardiomyopathy Y/N
Respiratory involvement
Y/N
1 M 62 Flat feet, difficulty climbing stairs 45 2335 Yes Yes
2 M 64 Poor running and falls 15 2471 Yes Yes
3 F 58 Difficulty getting out of a chair and
climbing stairs
43 n/a Yes No
4 M 46 Weight loss 23 1212 Yes No
5 F 55 Difficulty climbing stairs and falls 41 n/a No No
6 M 21 Toe walker and slow at running 9 8050 Yes No
7 F 25 Slow at running and odd gait when
climbing stairs
9 2600 No Yes
8 M 33 Raised CK detected when giving
blood.
Early 20’s 12000 No No
9 M 28 Recurrent falls 24 3302 Yes No
10 M 39 Poor at sport in school, unable to
climb ropes.
10 n/a Yes No
11 M 54 Poor running and myoglobinuria Late 40’s 1000 Yes No
12 M 37 Recurrent falls Early teens n/a No No
13 F 41 Slow at running and unable to climb
school wall
10 222 No No
14 F 46 Difficulty climbing stairs 22 856 No Yes
15 F 46 Difficulty climbing stairs after first
pregnancy
31 n/a No No
16 F 29 Pain in thighs and difficulty climbing
stairs
12 13414 No No
17 F 45 Difficulty climbing stairs 23 421 No No
18 M 50 Difficulty climbing stairs 37 4950 Yes No
19 M 30 Pain in buttocks and thighs 15 7545 No No
20 F 27 Difficulty descending stairs 17 23858 No No
21 F 30 Pain and cramps in legs 10 n/a No No
22 F 31 Cramps in calf muscles 10 2446 No No
23 M 36 Difficulty getting out of a chair 20 11421 No No
24 F 47 Poor at running 10 1940 No Yes
25 M 18 No symptoms Nil 3000 No No
26 M 28 Cramps, myalgia 17 7000 Yes No
27 M 51 Difficulty in running 14 1535 Yes Yes
28 F 43 Cramps, myalgia 13 7260 No No
29 F 42 Fatigability and difficulty climbing
stairs
33 1528 Yes No
30 F 40 Cramps, myalgia 6 3170 No No
31 F 26 Cramps, myalgia 7 5000 No No
32 F 38 Fatigability and weakness in lower
limbs
16 5155 Yes No
33 M 51 Fatigue with physical activities 37 n/a Yes No
34 F 58 Falling over 38 n/a Yes Yes
35 F 40 Difficulty getting out of a chair 32 n/a No No
36 M 64 Difficulty getting up from the floor 43 n/a
37 M 45 Difficulty climbing stairs 34 n/a No No
38 M 21 Difficulty running and rising from a
chair
10 n/a Yes Yes
doi:10.1371/journal.pone.0090377.t001
Quantitative MRI in LGMD2I
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Functional testing
Functional tests were performed in the patients at the time of
MRI to add information on clinical severity, with the 4 centres
working to a standardised manual. These tests included myometry
strength measurement using a hand held myometer (measuring
hip flexion and extension, knee flexion and extension, ankle
dorsiflexion and plantar flexion), the 6 minute walk distance
(6MWD), the 10 metre walk, the timed chair rise, timed stair climb
and timed stair descent (using 4 standard stairs with rails) and the
‘timed up and go’ (TUG) test. Forced vital capacity (FVC) was
measured as the best of three attempts using a hand-held
spirometer with the patient in a sitting and then in a supine
position and related to the expected value for patient height.
Statistical Methods
The Shapiro-Wilk test was used to demonstrate that the
measured variables were not normally distributed. Non-paramet-
ric statistical tests were used for analyses using the SPSS version
17.0 software (IBM, USA). Spearman’s rank correlation (coeffi-
cient reported as rs) was used to compare the Dixon quantitative
fat analysis values and the qualitative scores. Comparisons of the
fat fractions between the muscles were analysed using the
Wilcoxon signed-rank test and between genders using the Mann-
Whitney U test.
Results
The patients represented the broad phenotypic spectrum that is
commonly observed in patients with the common c.826C.A
mutation in the FKRP gene. The spectrum ranged from
asymptomatic patients to those who were almost non ambulant
and just able to walk 50 m. This is detailed in Table 1, with onset
of symptoms in childhood (less than 16 years) recorded in
approximately half the study group (47%) with just over a quarter
(26%) of the group developing symptoms aged 10 years or
younger.
The most frequent first symptoms were difficulty in climbing
stairs (28%), difficulty in running (21.1%) and myalgia and cramps
(21.1%). The creatine kinase was recorded in 32 of the 38
participants and ranged from 222 units/l to 23,858 units/l, with a
mean of 5,142 units/l.
Respiratory involvement as reported by the patients was present
in 21% (n= 8) of the cohort, however, 33.3% had a sitting FVC,
75% predicted value for their height, and this rose to 69.0% for
lying FVC. 16.6% had a.20% decrease in their FVC from sitting
to lying and 33.3% had a 10–19% drop in their FVC from sitting
to lying. 31% of the cohort that had a cardiomyopathy also had
respiratory involvement (n = 5).
Table 2. Percentage of LGMD2I patients in each category of
each semi-quantitative grade for individual muscle groups
using the Mercuri et al. scale, with the median grade for each
muscle.
Semi quantitative grade 0 1 2a 2b 3 4
Median
grade
Muscle
Gluteus Maximus (GM) 0 0 10.5 10.5 26.3 52.6 4
Biceps Femoris long head
(BFLH)
0 2.6 10.5 10.5 13.2 63.2 4
Semitendinosus (ST) 0 5.3 13.2 10.5 31.6 39.5 3
Semimembranosus (SM) 0 0 18.4 26.3 18.4 36.8 3
Biceps Femoris short head
(BFSH)
0 8.6 31.4 25.7 25.7 8.6 2b
Sartorius (SAR) 2.6 7.9 34.2 28.9 21.1 5.3 2b
Vastus Medialis (VM) 0 15.8 26.3 13.2 26.3 18.4 2b
Gracilis (GRAC) 2.6 10.5 42.1 13.2 21.1 10.5 2a
Vastus Lateralis (VL) 5.3 5.3 21.1 28.9 28.9 10.5 2b
Rectus Femoris (RF) 10.5 15.8 26.3 21.1 15.8 10.5 2a
Medial Gastrocnemius (MG) 5.3 7.9 18.4 23.7 21.1 23.7 2b
Lateral Gastrocnemius (LG) 2.6 18.4 18.4 23.7 28.9 7.9 2b
Peroneus Longus (PL) 0 18.4 26.3 34.2 18.4 2.6 2b
Soleus (SOL) 2.6 5.3 42.1 26.3 18.4 5.3 2a
Tibialis Anterior (TA) 7.9 34.2 47.4 10.5 0 0 2a
doi:10.1371/journal.pone.0090377.t002
Figure 1. T1 weighted images of the lower leg in LGMD2I
patients with increasing severity in pathology (a–e), and in a
control subject (f). In image (a) there is involvement of medial
gastrocnemius and soleus compared to image (e) where all muscles but
tibialis anterior are severely affected. (TA= tibialis anterior, SOL=
soleus, PL = peroneus longus, LG= lateral gastrocnemius, MG= medial
gastrocnemius).
doi:10.1371/journal.pone.0090377.g001
Figure 2. T1 weighted images of the thigh in LGMD2I patients
with increasing stages of severity and fat content (a–e), and in
a control subject (f). In (a) this is almost normal, however in (e) only
sparing of gracilis and sartorius is seen. (VL = vastus lateralis, SM=
semimembranosus, ST = semitendinosus, BFLH= biceps femoris long
head, SAR= sartorius, GRAC= gracilis, RF = rectus femoris).
doi:10.1371/journal.pone.0090377.g002
Quantitative MRI in LGMD2I
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Cardiomyopathy was present in 16 of the 38 patients (42%) as
documented on echocardiography results. 77% of those with
cardiomyopathy were male and 23% female, the age range was
21–64 years, with a mean age of 44.4 years and 25% of those with
a cardiomyopathy were in their 20’s and all male.
Analysis of T1w images
Pelvis, thigh and lower leg T1w images were analysed for both
the control and patient group. The detailed distribution of grades
amongst the 38 patients broken down per muscle group, along
with the median grade for the muscle group is given in Table 2. In
all 8 control subjects more than 95% of the muscles assessed were
normal (grade 0) compared to the patient group, where less than
2% of the muscles assessed were normal and over 41% scored
grades 3 or 4. There was a wide variation in median grades
between muscle groups, with the thigh muscles generally more
affected than those of the lower leg. Although the gluteus maximus
muscle was not imaged quantitatively, the analysis of the T1w
images revealed that 80% of the patients scored grade 3 or 4. The
intraclass correlation coefficient between the two raters was 0.83,
reflecting absolute agreement in scoring for 65% of assessments:
the lowest agreement was for grade 2b, with 39% concurrence.
In the lower leg, involvement of the gastrocnemii and soleus
muscles was most noticeable with relative sparing of the tibialis
anterior muscle until a late stage (Figure 1A–E). This was most
striking in patients who had relatively severe involvement of the
gastrocnemii with little change in the tibialis anterior muscles. The
fat content and pattern seen in the lower leg muscles was distinct,
with a variegated, striped appearance of the soleus (Figure 1A–C)
and a lacy, reticular pattern in both lateral and medial
gastrocnemius, commencing initially from the internal borders
(Figure 1B & D). The peroneus longus muscle demonstrated ‘salt
and pepper’ speckling (Figure 1B & E).
In the thigh it has been reported that initially posterior
involvement is seen, followed by a gradual increase in fat content
and extension of pathological changes to involve the anterior thigh
muscles as the disease progresses [18,19]. In our cohort the biceps
femoris (long head) muscle was most severely affected with the
semimembranosus and the semitendinosus muscles next
(Figure 2B–E). These muscles had a reticular pattern of
involvement again from the more internal borders out to the
periphery (Figure 2C). The vastus lateralis muscle was generally
spared until late in the disease process. The vastus lateralis muscle
demonstrated peripheral sparing (Figure 2D), a reverse of the
pattern in Bethlem and Ullrich congenital myopathy [20]. The
sartorius and gracilis muscles were relatively spared and had a
stippled appearance with hypertrophy when affected (Figure 2A,
B, C & E). The rectus femoris was also relatively spared with gross
Figure 3. The grey bars illustrate the quantitative fat fractions for LGMD2I patients with median qualitative score at the left of the
bars. The grey box indicates the lower and upper quartiles, with the median represented as a bar within the grey box and the stems the range (the
outliers more than 1.5 interquartile range are marked separately as dots). (BFLH= biceps femoris long head, ST = semitendinosus, SM=
semimembranosus, BFSH= biceps femoris short head, SAR= sartorius, VM= vastus medialis, GRAC= gracilis, VL = vastus lateralis, RF = rectus
femoris, MG= medial gastrocnemius, LG = lateral gastrocnemius, PL = peroneus longus, SOL= soleus, TA = tibialis anterior).
doi:10.1371/journal.pone.0090377.g003
Table 3. The median values of fat fraction (%) in the patient
group and the control group.
Muscle
Median
LGMD2I
Median
Control P value
Biceps Femoris long head
(BFLH)
69.7 3.9 0.0001
Semitendinosus (ST) 49.0 2.3 0.00001
Semimembranosus (SM) 48.6 2.9 0.0001
Biceps Femoris short head
(BFSH)
25.5 3.2 0.001
Sartorius (SAR) 24.2 3.9 0.001
Vastus Medialis (VM) 23.3 3.0 0.01
Gracilis (GRAC) 16.4 3.0 0.0001
Vastus Lateralis (VL) 14.3 5.5 0.04
Rectus Femoris (RF) 9.4 3.3 0.03
Medial Gastrocnemius (MG) 25.1 2.2 0.001
Lateral Gastrocnemius (LG) 19.4 2.1 0.001
Peroneus Longus (PL) 16.0 4.9 0.01
Soleus (SOL) 10.5 3.0 0.001
Tibialis Anterior (TA) 5.9 2.8 0.02
The p values represent Mann-Whitney U test between patients and controls.
doi:10.1371/journal.pone.0090377.t003
Quantitative MRI in LGMD2I
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hypertrophy in clinically less severe participants (21.1% of study
cohort) (Figure 2D). Atrophied recti were seen in patients with
more extensive changes.
Quantitative fat imaging
Nine muscles at the mid thigh level and five muscles at the mid
lower leg level, a total of 14 muscles per patient, were analysed in
all 38 patients and 8 control subjects: Figure 3 summarises the
quantitative results demonstrating that the degree of muscle
pathology varied significantly from severe, as in the biceps femoris
long head muscle (median fat fraction 69.7%), to very mild
involvement in the tibialis anterior muscle (median fat fraction
5.9%). In the controls, the median fat fraction in all muscle groups
ranged from 2.08% to 5.53%. Figure 3 also demonstrates how the
severity of muscle pathology is spread with the most severely
affected muscles being the biceps femoris long head muscle,
followed by the semimembranosus and semitendinosus muscles,
with rectus femoris and vastus lateralis muscles relatively spared in
the thigh. In the lower leg, medial and lateral gastrocnemius
muscles are more severely affected with tibialis anterior muscle
relatively spared. Table 3 highlights that all muscles assessed
quantitatively in the LGMD2I cohort were affected compared to
the control group.
The pattern of involvement is illustrated in the quantitative fat
fraction images of Figure 4, with increasing severity in the thigh
from an asymptomatic LGMD2I patient (a), with a semimembra-
nosus (SM) fat fraction of 4.1%, to a more severely affected patient
(e), with SM fat fraction of 51.8%. These are the same patients as
Figure 2. Comparison of the T1w scoring and the quantitative fat
imaging across all muscles showed correlation (rs = 0.87 and p,
0.01), but with significant overlap of fat fractions between
Figure 4. Quantitative fat images of the thigh in LGMD2I patients with increasing stages of severity and increasing fat fraction (a–
e), and in a control subject (f). In (a) this is almost normal, however in (e) only sparing of gracilis (fat fraction 13.7%) and sartorius (24.0%) is seen.
(SM= semimembranosus, ST = semitendinosus, GRAC= gracilis, SAR = sartorius).
doi:10.1371/journal.pone.0090377.g004
Figure 5. This figure compares the results of quantitative
Dixon imaging with the semi-quantitative grading, demon-
strating the wide range of fat fractions that can exist within the
same grade (rs = 0.87, p,0.01). The grey bars represent the middle
50% of the distribution between the upper and lower quartile and their
corresponding fat fraction. The dots and stars represent outliers beyond
1.5 and 3.0 times the interquartile range beyond the upper quartile
respectively.
doi:10.1371/journal.pone.0090377.g005
Table 4. Median values of fat fraction for the study cohort
stratified by gender (19 males and 19 females).
Muscle Male Female
Semitendinosus (ST) 51.8 45.3
Semimembranosus (SM) 56.2* 28.2
Sartorius (SAR) 24.0 25.1
Gracilis (GRAC) 13.7** 25.0
Vastus Lateralis (VL) 11.2 18.2
Vastus Medialis (VM) 45.71 18.9
Medial Gastrocnemius (MG) 22.2 28.0
Lateral Gastrocnemius (LG) 15.1{ 33.7
It illustrates significant differences between the anterior thigh muscles in the
male group and preferential sparing of the gracilis compared to sartorius. These
features are not found in the female group.
* p = 0.05 compared to male ST.
** p = 0.01 compared to male SAR.
1p,0.005 compared to male VL.
{p=0.05 compared to male MG.
doi:10.1371/journal.pone.0090377.t004
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qualitative grades (Figure 5). The inter-observer Bland-Altman
analysis of quantitative fat imaging gave an inter-observer bias of
0.04% (no systematic bias) and an inter-observer repeatability
coefficient of 1.43% (95% of comparisons fall within this range).
The test-retest analyses with subject repositioning showed that the
inter-scan repeatability coefficient in the fat fraction was 0.6%
(with insignificant bias: 0.02%).There were some striking gender
differences in muscle pathology in our LGMD2I cohort (Table 4),
despite the fact that there was no difference in age, disease
duration, or clinical severity as represented by 6MWD or FVC
(Table S1 in File S1). In the female group there was diffuse
involvement of both the gastrocnemii muscles; however, in the
male group, the lateral gastrocnemius muscle had less fat
infiltration. This contrasts with previous LGMD2I studies
[18,19], which reported diffuse and equal involvement of medial
and lateral gastrocnemius compared to LGMD2A, where medial
gastrocnemius is more involved than lateral gastrocnemius.
The hamstrings have previously been reported as more severely
affected compared to the anterior thigh muscles [18,19]. In the
female subjects, there was a trend towards semimembranosus
being spared relative to semitendinosus (median 28.2% compared
with 47.3%). In males, these muscles were similarly affected,
56.2% and 51.8% respectively. The gracilis and sartorius muscles
have previously been reported as being relatively and equally
spared [18,19]. In our male cohort, the gracilis muscle was more
preserved compared to the sartorius muscle (Table 4, p = 0.01). In
the female group, the gracilis and sartorius muscles were equally
affected. The anterior thigh muscles also demonstrated gender
differences; in the female subjects, the vastus lateralis and vastus
medialis were affected similarly (18.2% and 18.9%), whilst in the
male subjects there was a greater degree of fat infiltration, 45.7%
in the vastus medialis compared to 11.2% in the vastus lateralis
(p,0.005). This is shown in Figure 6 which compares similarly
affected male and female patients with LGMD2I: preservation of
the vastus medialis muscle seen in the female patient compared to
the increased fat content and pathological changes seen in this
muscle in the male patient.
Functional correlations with MRI changes
Strong correlations were demonstrated between myometry
measures and fat infiltration in appropriately tested muscle groups.
The ‘hamstring average fat fraction’ (the average of the combined
fat fraction for semimembranosus, semitendinosus and biceps
femoris muscle for each individual) correlated strongly with knee
flexion strength r =2.73 (p,0.01) (figure 7) and the TUG test
(r = .580, P,0.02). There was also strong correlation between
‘hamstring average fat fraction’ and the stair climb (r = .52, p,
0.01), the stair descent (r = .46, p,0.01) and the 6MWD (r =2.79,
p,0.01) (figure 8).
The vastus lateralis muscle (r =20.75), vastus medialis muscle
(r =20.68) and the rectus femoris muscle fat fractions (r =20.79)
correlated strongly with knee extension strength. All were
Figure 6. Comparison of the thigh muscles in (a) a male LGMD2I patient with more advanced pathology and increased fat content
seen in the vastus medialis muscle (72.2%) and (b) preservation of the vastus medialis muscle (9.7%) of a female LGMD2I patient.
(VM= vastus medialis, VL = vastus lateralis).
doi:10.1371/journal.pone.0090377.g006
Figure 7. Strong correlation between knee flexion strength (in
pounds) and hamstring average fat fraction, r =2.73 (p,0.01).
doi:10.1371/journal.pone.0090377.g007
Figure 8. Strong correlation between 6 minute walk distance
(6MWD) and hamstring average fat fraction, r =2.79 (p,0.01).
doi:10.1371/journal.pone.0090377.g008
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significant; p = 0.01. The ‘quadriceps average fat fraction’ (the
average of the combined fat fraction for vastus lateralis, vastus
medialis and rectus femoris muscle for each individual) strongly
correlated with the stair climb (r = .718, p,0.01), the 6MWD
(r =2.832, p,0.01), the timed chair rise (r = .743, p,0.01) and
the TUG test (r = .753, p,0.01).
The 6MWD, used as an outcome measure in many clinical
trials, strongly correlated with ‘average fat fraction’ (r =20.80, p,
0.01) (the average of the combined fat fraction of all 14 muscles
analysed and calculated for each individual).
Discussion
This is the largest reported cross-sectional MRI study (n = 38) of
patients with LGMD2I due to the common mutation in the FKRP
gene. Both traditional qualitative grading and quantitative fat
imaging were applied to measure the differing degrees and
patterns of muscle involvement and fat fractions. Attaining such a
detailed natural history of a condition and its progression is vital as
a basis for translating scientific research into a meaningful
treatment. In LGMD2I disease progression and severity is
heterogeneous and therefore objective reliable biomarkers are
important. MRI is non-invasive, potentially objective and does not
rely on patient effort compared to clinical and physical measures
that are currently employed.
Previous reports of qualitative T1w MRI analysis in LGMD2I
patients have demonstrated pathology preferentially in the
posterior thigh muscles [5,6,18,19,21]. More specifically the
changes seem to occur in the biceps femoris and internal adductor
muscles first and with further disease progression to involve the
rest of the hamstring muscles and to a lesser degree the vastus
intermedius and lateralis muscles. Involvement of the vastus
medialis and rectus femoris muscles has only been observed in
those patients with advanced disease [19]. Our results confirmed
the qualitative findings of these previous studies, but we have also
demonstrated that in the male group there was a more severe and
earlier involvement of the vastus medialis compared to the vastus
lateralis muscle, not seen in the female group. This has not
previously been documented in the published literature or
reported in any other muscular dystrophy to date. In the lower
leg, the gastrocnemius muscles have previously been reported as
having diffuse and equal involvement [18,19]. In our patient
cohort, the male group demonstrated a predominantly medial
involvement. This could mean that female patients with FKRP
mutations phenotypically present differently to the male patients.
This has been demonstrated in LGMD2L where female patients
with ANO5 mutations present and progress differently to male
patients [22].
The use of MRI as a diagnostic tool has importance in many
neuromuscular diseases; however, it does need to be used in
conjunction with other assessments, such as clinical findings and
muscle biopsy information. Whilst there are certain imaging
patterns that appear to be pathognomonic, as in Bethlem
myopathy and Ullrich myopathy [20], in LGMD2I there are
similarities to other LGMDs, such as Calpainopathy (LGMD2A).
In both these conditions, posterior thigh and lower leg involve-
ment predominate, although it has been reported previously that
there are differences in gastrocnemii muscle involvement, and that
the vastus lateralis appears more spared in LGMD2A compared to
LGMD2I. This, however, was not seen in our cohort of patients.
Comparison of the qualitative grades with the quantitative fat
fractions showed that each grade corresponded to a very wide
range of fat fractions, and whilst patterns of muscle pathology can
be defined qualitatively, detecting small pathological changes in
individual patients would be impossible using this system. In
comparison, the quantitative method offers an increased discrim-
ination and a more robust measure of muscle involvement for both
cross-sectional and longitudinal studies. The inter-observer anal-
ysis suggests that these quantitative measures are highly observer
independent.
This work also suggests that optimal target muscles for
longitudinal assessment of pathological changes can be identified.
The most suitable muscles are likely those demonstrating a range
of fat fractions within the cohort, but are neither at the extremes of
severity as with the biceps femoris (long head), semimembranosus
and semitendinosus muscles, nor having limited involvement, such
as the tibialis anterior muscle. Candidate muscles should also be
easy to delineate on the MRI scans with well defined ROIs. The
muscles that fulfil these criteria are the vastus lateralis, gracilis,
rectus femoris and the gastrocnemii muscles. The inter-observer
analysis showed that the results of quantitative analysis are highly
objective.
A number of studies have addressed the more severe type of
muscular dystrophy, Duchenne muscular dystrophy (DMD),
highlighting both the disease natural history and its effect on
muscles assessed by MRI [7,21]. DMD is now a subject of clinical
trials where, at present, therapeutic success is assessed by muscle
biopsy and by functional outcomes, such as the six minute walk
distance (6MWD). These tests, however, are either invasive or are
highly dependent on patient cooperation. In comparison, MRI
may provide markers that are both non-invasive, objective and as
shown correlate highly with functional assessments, in particular
the 6MWD, used in trials, and myometry strength testing.
Although this was the largest LGMD2I cohort studied with
MRI to date, patient numbers remained relatively small, and
future studies will benefit from widening the inclusion criteria to
include both asymptomatic and paediatric patients. Measurements
were also limited to quantification of the Dixon scans at one mid-
point level in the lower leg and thigh. More sophisticated analyses
may permit fat fraction determination at all levels in order to
quantify the variability that is seen within each muscle. This may
provide further insights into the process of muscle damage
occurring in this condition. In addition to distributions of muscle
involvement consistent with previous reports, we demonstrated a
new observation of gender-dependent patterns. MRI fat fraction
quantification provides objective measures of muscle pathology
which are more definitive than the previous qualitative technique,
and may provide a means to monitor previously undetectable
small levels of change in longitudinal studies.
Supporting Information
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